Front Row Advisors’s Steris STE Stock Holding History
Bought
Maintained
Sold
Other funds holding STE
GIM
Front Row Advisors's STE Position: Q3 2024 in Review
Front Row Advisors sold out of Steris (STE) in Q3 2024, closing a stake of 6 shares — an estimated $1.32K sold.
Front Row Advisors first reported a position in STE in Q1 2018 and held it in 25 quarters. The position peaked at $9K in Q1 2022. 759 funds tracked by Wall St. Rank hold STE as of Q3 2024.
- Front Row Advisors reported no remaining Steris position as of Q3 2024 after selling out during the quarter.
- Front Row Advisors sold 6 Steris shares in Q3 2024, an estimated $1.32K.
- Front Row Advisors first reported a position in Steris in Q1 2018 and held it in 25 quarters.
- Front Row Advisors's Steris position peaked at $9K in Q1 2022.
- 759 funds tracked by Wall St. Rank held Steris as of Q3 2024.
Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.